{"id":2081,"date":"2026-06-07T02:00:00","date_gmt":"2026-06-07T05:00:00","guid":{"rendered":"https:\/\/sevenresiduosaude.com.br\/blog\/?p=2081"},"modified":"2026-06-07T02:00:00","modified_gmt":"2026-06-07T05:00:00","slug":"pgrss-endocrinologia-dm1-dm2-tireoide-suprarrenal-hipofise-osteoporose-glp1-insulina","status":"publish","type":"post","link":"https:\/\/sevenresiduosaude.com.br\/blog\/pgrss-endocrinologia-dm1-dm2-tireoide-suprarrenal-hipofise-osteoporose-glp1-insulina\/","title":{"rendered":"PGRSS end\u00f3crino: DM1, DM2, tireoide, hip\u00f3fise"},"content":{"rendered":"<p>A regula\u00e7\u00e3o brasileira de RSS \u00e9 frequentemente desafiada por gestores de centros de endocrinologia. Em 2026, h\u00e1 uma demanda crescente de hospitais e cl\u00ednicas com unidade end\u00f3crina \u2014 <strong>diabetes tipo 1 DM1<\/strong> com bomba de insulina Medtronic 780G \/ Tandem t:slim X2 \/ Insulet Omnipod 5 + sensor CGM Dexcom G7 \/ Freestyle Libre 3 \/ Medtronic Guardian 4 + insulina Lantus\/Tresiba\/Toujeo basal + Humalog\/NovoRapid\/Apidra prandial Lista C5 cadeia fria, <strong>DM2 com insulinoterapia + GLP-1 + SGLT-2 inibidor<\/strong> semaglutida Ozempic\/Rybelsus + tirzepatida Mounjaro + dulaglutida Trulicity + dapagliflozina Forxiga + empagliflozina Jardiance + canagliflozina Invokana, <strong>tireoide<\/strong> com tireoidectomia total + I-131 abla\u00e7\u00e3o radioativo CNEN-NN-3.05 + levotiroxina Synthroid\/Puran T4 supress\u00e3o TSH, <strong>adrenal<\/strong> com adrenalectomia laparosc\u00f3pica\/rob\u00f3tica + feocromocitoma + metanefrina + hidrocortisona + fludrocortisona Lista C5, <strong>hip\u00f3fise<\/strong> com cirurgia transesfenoidal + gigantismo\/acromegalia somatotropina + prolactinoma cabergolina + Cushing cetoconazol + diabetes insipidus desmopressina, <strong>osteoporose<\/strong> com densitometria DEXA + alendronato Fosamax \/ risedronato Actonel \/ zoledronato Aclasta + denosumab Prolia \/ romosozumab Evenity Lista C5 + teriparatida Forteo \/ abaloparatida Tymlos PTH analog, <strong>gonadal<\/strong> com testosterona Nebido \/ oestradiol + progesterona TRH + ICSI\/FIV. A consequ\u00eancia \u00e9 a urg\u00eancia de <strong>PGRSS dedicado para endocrinologia<\/strong> \u2014 captura de <strong>bomba de insulina<\/strong> Medtronic 780G + Tandem t:slim X2 + Insulet Omnipod (R$ 18-35k cada + reservat\u00f3rio descart\u00e1vel + cateter set 3 dias \u00d7 100-300 dias\/ano), <strong>sensor CGM<\/strong> Dexcom G7 \/ Freestyle Libre 3 \/ Medtronic Guardian 4 (R$ 200-500\/sensor \u00d7 14 dias \u00d7 100-300 pacientes\/ano), <strong>insulina + GLP-1 Lista C5<\/strong> Lantus\/Tresiba\/Toujeo basal + Humalog\/NovoRapid\/Apidra prandial + Ozempic\/Rybelsus\/Mounjaro\/Trulicity (R$ 1.5-3.5k\/m\u00eas\/paciente \u00d7 500-2.000 pacientes = R$ 9-84M\/ano), <strong>caneta de auto-aplica\u00e7\u00e3o<\/strong> FlexTouch \/ FlexPen \/ SoloStar \/ KwikPen descart\u00e1vel, <strong>agulha de insulina ultrafina<\/strong> 4-8mm 32G descart\u00e1vel + lanceta de glicemia + tira de teste, <strong>iodo radioativo I-131<\/strong> abla\u00e7\u00e3o tireoide ponto-de-uso CNEN + livro reten\u00e7\u00e3o 5 anos, <strong>bisfosfonato Aclasta IV<\/strong> zoledronato 5mg\/100mL R$ 4-8k\/dose \u00d7 1\/ano, <strong>denosumab Prolia\/Evenity romosozumab<\/strong> SC R$ 3-6k\/dose \u00d7 6 meses Lista C5, <strong>teriparatida Forteo \/ abaloparatida Tymlos<\/strong> caneta di\u00e1ria PTH analog Lista C5 R$ 4-8k\/m\u00eas, <strong>kit metanefrina urin\u00e1ria 24h<\/strong> + frasco coleta + \u00e1cido clor\u00eddrico preservativo. A realidade \u00e9 que end\u00f3crino produz RSS de alt\u00edssima rotatividade. <strong>PGRSS de endocrinologia \u00e9 cadeia integrada<\/strong> \u2014 come\u00e7a no <strong>diagn\u00f3stico<\/strong> (HbA1c + tireoidograma + cortisol + RM hip\u00f3fise + DEXA + metanefrina), passa pelo <strong>tratamento<\/strong> (bomba + GLP-1 + I-131 + bisfosfonato + cirurgia) e termina no <strong>monitoramento cr\u00f4nico<\/strong> (CGM + bioqu\u00edmica trim + densitometria 2y). O conjunto soma <strong>R$ 22.000-45.000\/m\u00eas<\/strong> que muitos gestores subestimam.<\/p>\n<p>Para o gestor que opera ou planeja unidade endocrinologia, \u00e9 fundamental considerar a complexidade desde o in\u00edcio.<\/p>\n<h2>Os procedimentos endocrinologia e os RSS espec\u00edficos<\/h2>\n<p>Em uma opera\u00e7\u00e3o de qualquer porte, a cadeia gera RSS espec\u00edficos.<\/p>\n<table>\n<thead>\n<tr>\n<th>Procedimento<\/th>\n<th>Insumo cr\u00edtico<\/th>\n<th>F\u00e1rmaco<\/th>\n<th>Risco RSS<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Bomba insulina + CGM<\/td>\n<td>Reservat\u00f3rio+sensor descart\u00e1vel<\/td>\n<td>Insulina basal+prandial Lista C5<\/td>\n<td>A4 + B + RBI<\/td>\n<\/tr>\n<tr>\n<td>GLP-1 Ozempic\/Mounjaro<\/td>\n<td>Caneta FlexTouch + ultrafina<\/td>\n<td>Semaglutida\/tirzepatida C5<\/td>\n<td>A4 + B Lista C5<\/td>\n<\/tr>\n<tr>\n<td>I-131 tireoide<\/td>\n<td>C\u00e1psula iodo radioativo<\/td>\n<td>I-131 30-150 mCi CNEN<\/td>\n<td>A4 + radioativo CNEN<\/td>\n<\/tr>\n<tr>\n<td>Densitometria DEXA<\/td>\n<td>Equipamento + filme<\/td>\n<td>N\u00e3o-aplic\u00e1vel<\/td>\n<td>A4 + RAEE DEXA<\/td>\n<\/tr>\n<tr>\n<td>Bisfosfonato Aclasta IV<\/td>\n<td>Bolsa infus\u00e3o zoledronato<\/td>\n<td>Zoledronato Lista C5<\/td>\n<td>A4 + B Lista C5<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>A soma t\u00edpica \u00e9 entre <strong>R$ 22.000-45.000\/m\u00eas<\/strong> em PGRSS dedicado de endocrinologia vs <strong>R$ 8.000-18.000<\/strong> em PGRSS gen\u00e9rico subdimensionado.<\/p>\n<h2>A bomba de insulina + CGM + insulinoterapia: o procedimento DM1 cont\u00ednuo<\/h2>\n<p>A primeira camada do desafio \u00e9 o DM1. Padr\u00e3o setorial inclui (a) <strong>bomba de insulina<\/strong> Medtronic MiniMed 780G AHCL \/ Tandem t:slim X2 Control-IQ \/ Insulet Omnipod 5 R$ 18-35k cada + reservat\u00f3rio descart\u00e1vel + cateter set 3 dias; (b) <strong>CGM Continuous Glucose Monitoring<\/strong> Dexcom G7 \/ Freestyle Libre 3 \/ Medtronic Guardian 4 sensor 14 dias + transmissor; (c) <strong>insulina basal Lista C5<\/strong> Lantus glargina U-100 \/ Tresiba degludeca \/ Toujeo glargina U-300 + <strong>insulina prandial<\/strong> Humalog lispro \/ NovoRapid asparte \/ Apidra glulisina; (d) <strong>caneta de auto-aplica\u00e7\u00e3o<\/strong> FlexTouch + KwikPen + SoloStar descart\u00e1vel + agulha 4-6mm 32G; (e) <strong>livro RBI bomba + sensor<\/strong> com reten\u00e7\u00e3o 10 anos.<\/p>\n<p>Hospital com 200-600 DM1s\/ano \u00d7 R$ 25k bomba + R$ 18k\/ano CGM + R$ 5k\/ano insulina = R$ 9.6-30M\/ano em insulinoterapia + RBI. Como discutimos no post sobre <a href=\"https:\/\/sevenresiduosaude.com.br\/blog\/pgrss-utin-neonatal-surfactante-ecmo-sepse-prematuro-extremo-baixo-peso-neonatologia\/\">PGRSS de UTIN<\/a>, Lista C5 + cadeia fria \u00e9 estruturante.<\/p>\n<h2>O GLP-1 + SGLT-2 + DM2 + tireoide: o est\u00e1gio Lista C5 alta volumetria<\/h2>\n<p>A segunda camada \u00e9 o DM2 + tireoide. Padr\u00e3o setorial inclui (a) <strong>GLP-1 agonista<\/strong> semaglutida Ozempic\/Wegovy 1mg-2.4mg semanal + Rybelsus oral + <strong>tirzepatida Mounjaro<\/strong> dual GIP+GLP-1 + dulaglutida Trulicity Lista C5 R$ 1.5-3.5k\/m\u00eas; (b) <strong>SGLT-2 inibidor<\/strong> dapagliflozina Forxiga + empagliflozina Jardiance + canagliflozina Invokana R$ 200-500\/m\u00eas; (c) <strong>tireoidectomia total<\/strong> com I-131 abla\u00e7\u00e3o 30-150 mCi p\u00f3s-op + levotiroxina supress\u00e3o TSH; (d) <strong>adrenalectomia laparosc\u00f3pica<\/strong> + cabergolina prolactinoma + transesfenoidal + Cushing; (e) <strong>densitometria DEXA<\/strong> + bisfosfonato Aclasta zoledronato IV + denosumab Prolia + teriparatida Forteo PTH analog.<\/p>\n<p>Hospital com 500-2.000 DM2s + 100-300 tireoides + 50-150 osteoporoses \u00d7 R$ 2.5k m\u00e9dio\/m\u00eas = R$ 19-72M\/ano em Lista C5.<\/p>\n<h2>A osteoporose + bisfosfonato + denosumab: o est\u00e1gio cr\u00f4nico<\/h2>\n<p>A terceira camada \u00e9 a osteoporose. Padr\u00e3o setorial inclui (a) <strong>densitometria DEXA Hologic \/ GE Lunar<\/strong> R$ 200-700\/exame + filme + EPI radioprote\u00e7\u00e3o; (b) <strong>alendronato Fosamax<\/strong> semanal + risedronato Actonel + ibandronato Boniva + <strong>zoledronato Aclasta IV<\/strong> 5mg\/100mL R$ 4-8k\/ano; (c) <strong>denosumab Prolia<\/strong> Amgen 60mg SC 6\/6 meses Lista C5 R$ 3-5k\/dose \/ <strong>romosozumab Evenity<\/strong> Amgen 210mg SC mensal \u00d7 12 meses R$ 5-8k\/dose; (d) <strong>teriparatida Forteo<\/strong> Lilly 20\u03bcg SC di\u00e1ria \u00d7 24 meses Lista C5 R$ 4-6k\/m\u00eas \/ <strong>abaloparatida Tymlos<\/strong> Radius Health PTH analog; (e) <strong>suplemento c\u00e1lcio + vitamina D<\/strong> + calcitonina nasal Miacalcin.<\/p>\n<p>Hospital com 200-600 osteoporoses\/ano \u00d7 30-50% Aclasta + 20-40% Prolia + 10-20% Forteo = R$ 1.5-12M\/ano em Lista C5 osteo.<\/p>\n<h2>Tr\u00eas perfis de PGRSS para endocrinologia<\/h2>\n<p><strong>PGRSS gen\u00e9rico subdimensionado.<\/strong> Sem cobertura espec\u00edfica para Lista C5 + I-131 + bomba\/CGM RBI. Custo mensal <strong>R$ 8.000-18.000<\/strong>, efic\u00e1cia limitada.<\/p>\n<p><strong>PGRSS dedicado intermedi\u00e1rio.<\/strong> Cobertura para insulina + GLP-1, sem I-131 + bisfosfonato + bomba\/CGM. Custo mensal <strong>R$ 18.000-32.000<\/strong>, efic\u00e1cia 100-200%.<\/p>\n<p><strong>PGRSS dedicado completo endocrinologia.<\/strong> DM1 + DM2 + tireoide + adrenal + hip\u00f3fise + osteoporose + integra\u00e7\u00e3o com <a href=\"https:\/\/sevenresiduosaude.com.br\/blog\/pgrss-bariatrica-metabolica-adolescente-sleeve-rygb-jovem-pediatrico-esg-obesidade-juvenil\/\">PGRSS de bari\u00e1trica adolescente<\/a>. Custo mensal <strong>R$ 32.000-45.000<\/strong>, ROI 250-500%.<\/p>\n<h2>Os tr\u00eas erros que aparecem em PGRSS endocrinologia subdimensionado<\/h2>\n<p>O primeiro \u00e9 o <strong>subdimensionamento de Lista C5 GLP-1 + insulina<\/strong>. Ozempic\/Mounjaro\/Lantus\/Humalog R$ 1.5-3.5k\/m\u00eas \u00d7 500-2.000 pacientes = cofre + cadeia fria.<\/p>\n<p>O segundo \u00e9 a <strong>aus\u00eancia de livro CNEN I-131<\/strong>. Iodo radioativo 30-150 mCi com reten\u00e7\u00e3o 5 anos + transporte SED.<\/p>\n<p>O terceiro \u00e9 a <strong>descarte de bomba de insulina + CGM como Grupo D<\/strong>. Medtronic 780G\/Tandem\/Omnipod R$ 18-35k s\u00e3o RAEE eletr\u00f4nico + retorno fabricante + livro RBI.<\/p>\n<p>A regula\u00e7\u00e3o de PGRSS no Brasil est\u00e1 em fase de moderniza\u00e7\u00e3o t\u00e9cnica acelerada com endocrinologia como prioridade. As institui\u00e7\u00f5es que estruturam PGRSS dedicado desde o in\u00edcio \u2014 alinhadas com <a href=\"https:\/\/sevenresiduosaude.com.br\/blog\/calendario-2026-compliance-rss-datas-fiscalizacao\/\">calend\u00e1rio 2026 de compliance<\/a> \u2014 atravessam o crescimento sem solavanco. Para gestores que precisam alinhar com gest\u00e3o paralela industrial, o <a href=\"https:\/\/sevenresiduos.com.br\/servicos\/\">portal Seven Res\u00edduos sobre servi\u00e7os completos<\/a> traz a perspectiva integrada. A <a href=\"https:\/\/www.endocrino.org.br\/\">SBEM Sociedade Brasileira de Endocrinologia e Metabologia<\/a> \u00e9 refer\u00eancia t\u00e9cnica.<\/p>\n<p><strong><a href=\"https:\/\/sevenresiduosaude.com.br\/orcamento\/\">Solicite cota\u00e7\u00e3o PGRSS de endocrinologia<\/a><\/strong> \u2014 cap\u00edtulo dedicado a bomba insulina Medtronic 780G\/Tandem t:slim\/Omnipod 5 + CGM Dexcom G7\/Freestyle Libre 3, GLP-1 Ozempic\/Mounjaro\/Trulicity + SGLT-2 Forxiga\/Jardiance, I-131 tireoide CNEN, bisfosfonato Aclasta + Prolia + Forteo Lista C5.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Endocrinologia gera RSS espec\u00edfico \u2014 DM1, DM2, tireoide, hip\u00f3fise, osteoporose. PGRSS dedicado.<\/p>\n","protected":false},"author":3,"featured_media":2080,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[2434,1953,1340,1951],"class_list":["post-2081","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-compliance-legislacao","tag-dm1","tag-endocrinologia","tag-glp-1","tag-tireoide"],"_links":{"self":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2081","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/comments?post=2081"}],"version-history":[{"count":1,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2081\/revisions"}],"predecessor-version":[{"id":4266,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/posts\/2081\/revisions\/4266"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media\/2080"}],"wp:attachment":[{"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/media?parent=2081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/categories?post=2081"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sevenresiduosaude.com.br\/blog\/wp-json\/wp\/v2\/tags?post=2081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}